Jefferies Financial Group Increases Teladoc Health (NYSE:TDOC) Price Target to $10.00

Teladoc Health (NYSE:TDOC) had its price target raised by stock analysts at Jefferies Financial Group from $8.00 to $10.00 in a research note issued on Tuesday, Briefing.com reports. The brokerage currently has a “hold” rating on the health services provider’s stock. Jefferies Financial Group’s price objective would indicate a potential upside of 22.47% from the stock’s previous close.

A number of other research firms also recently issued reports on TDOC. Truist Financial decreased their price objective on Teladoc Health from $15.00 to $10.00 and set a “hold” rating for the company in a report on Friday, August 2nd. Cantor Fitzgerald reiterated an “overweight” rating and issued a $10.00 price target on shares of Teladoc Health in a research note on Tuesday, August 20th. Canaccord Genuity Group dropped their price objective on shares of Teladoc Health from $25.00 to $17.00 and set a “buy” rating on the stock in a research note on Thursday, August 1st. Barclays reduced their price objective on Teladoc Health from $20.00 to $10.00 and set an “overweight” rating for the company in a research report on Thursday, August 1st. Finally, Deutsche Bank Aktiengesellschaft cut their price objective on shares of Teladoc Health from $15.00 to $10.00 and set a “hold” rating on the stock in a research report on Friday, August 2nd. Fifteen investment analysts have rated the stock with a hold rating and six have given a buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $12.31.

Teladoc Health Price Performance

Shares of NYSE TDOC opened at $8.17 on Tuesday. Teladoc Health has a 1 year low of $6.76 and a 1 year high of $22.54. The stock has a market capitalization of $1.40 billion, a P/E ratio of -5.79 and a beta of 0.90. The company’s 50-day moving average is $8.05 and its 200 day moving average is $11.02. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.66 and a quick ratio of 1.62.

Teladoc Health (NYSE:TDOC) last posted its earnings results on Wednesday, July 31st. The health services provider reported ($0.28) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.36) by $0.08. Teladoc Health had a negative return on equity of 10.25% and a negative net margin of 38.54%. The firm had revenue of $642.44 million for the quarter, compared to the consensus estimate of $649.34 million. On average, sell-side analysts expect that Teladoc Health will post -0.73 earnings per share for the current year.

Insider Buying and Selling at Teladoc Health

In other Teladoc Health news, insider Vidya Raman-Tangella sold 3,857 shares of the business’s stock in a transaction dated Friday, August 2nd. The stock was sold at an average price of $8.14, for a total transaction of $31,395.98. Following the completion of the sale, the insider now directly owns 33,667 shares in the company, valued at approximately $274,049.38. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. In related news, Director Thomas Mckinley bought 7,000 shares of the stock in a transaction that occurred on Tuesday, August 6th. The shares were bought at an average cost of $7.57 per share, for a total transaction of $52,990.00. Following the completion of the transaction, the director now owns 31,077 shares of the company’s stock, valued at $235,252.89. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Vidya Raman-Tangella sold 3,857 shares of the business’s stock in a transaction dated Friday, August 2nd. The shares were sold at an average price of $8.14, for a total value of $31,395.98. Following the sale, the insider now directly owns 33,667 shares of the company’s stock, valued at approximately $274,049.38. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 57,819 shares of company stock valued at $442,204. 0.95% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Several institutional investors have recently made changes to their positions in the stock. Victory Capital Management Inc. raised its stake in Teladoc Health by 23.3% during the 4th quarter. Victory Capital Management Inc. now owns 22,136 shares of the health services provider’s stock worth $477,000 after acquiring an additional 4,190 shares during the period. Charles Schwab Investment Management Inc. raised its position in shares of Teladoc Health by 6.7% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 1,654,116 shares of the health services provider’s stock valued at $35,646,000 after purchasing an additional 104,531 shares during the period. Principal Securities Inc. purchased a new position in shares of Teladoc Health during the 4th quarter valued at $45,000. Teacher Retirement System of Texas boosted its holdings in Teladoc Health by 18.8% in the 4th quarter. Teacher Retirement System of Texas now owns 23,382 shares of the health services provider’s stock worth $504,000 after buying an additional 3,695 shares during the period. Finally, Dimensional Fund Advisors LP increased its stake in Teladoc Health by 25.0% in the 4th quarter. Dimensional Fund Advisors LP now owns 3,834,422 shares of the health services provider’s stock worth $82,636,000 after buying an additional 767,999 shares in the last quarter. Institutional investors own 76.82% of the company’s stock.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.